Risk factors for cardiovascular and ischaemic heart disease in a Mediterranean country: Preliminary report of the Zaragoza study (ZACARIS-I)

Clinical Drug Investigation

Volumn 22, Issue 4, 2002, Pages 241-251

  Marín Ibáñez, Alejandro ^a   Bárcena Caamaño, Mario ^a   Fustero Fernández, Victoria ^a   Tisaire Sánchez, Javier ^a   Cucalón Arenal, José M ^a   González Ramos, José S ^a   Bueno Gómez, José ^b   Pintado Sandoval, Héctor ^a   Compaired Aragüés, Vicente ^a   Martín Ruiz, Aurelio ^c   Sol Maurí, Josep M ^d   Hernansanz Iglesias, Francisco ^a   Amores Ferreras, Manuel ^b   Hernández Herrero, Gonzalo ^d  

^a Centro de Salud San Jose Norte   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c Centro de Salud Delicias Norte   (Spain)

^d Parke Davis SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SPAIN;

EID: 0036239438     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222040-00004     Document Type: Article

References (34)

1. A general cardiovascular risk profile: The Framingham Study
2. Colestipol hydrochloride in hypercholesterolemic patients-effect on serum cholesterol and mortality
3. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis
4. The Lipid Research Clinics Coronary Primary Prevention Trial results
5. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia
6. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate
7. Test of effect of lipid lowering by diet on cardiovascular risk
8. La tensión arterial como factor de riesgo cardiovascular
9. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
10. Regresión de la hipertrofia ventricular izquierda ¿Cómo y por qué?
11. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
12. The Seven Countries Study: 2289 Deaths in 15 years
13. A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii
14. Summary of the Second Report of the National Cholesterol Education Program (NCEP)
15. Blood pressure studies in 14 communities: A two-stage screen for hypertension
16. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association: Clinical practice recommendations 1998
18. Morfologías de hipertrofia
19. Una revisión de más de 30000 radiografías de tórax normales
20. The Münster Heart Study (PROCAM). Results of follow-up at 8 years
21. Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population. The Manresa study, Spain
22. The CHD risk-map of Europe
23. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence
24. Epidemiology of essential hypertension: The Framingham experience
25. Epidemiology and risk of hypertension in the elderly: The Framingham Study
26. Prevalence of diabetes and impaired glucose tolerance in Aragón, Spain
27. Mortality differences between men and women following first myocardial infarction